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Supplementary Methods I: Detailed description of the study population 
 
Figure is previously published in: Alferink LJM, Kiefte-de Jong JC, Erler NS, et al. Association of dietary macronutrient 
composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study. Gut 2018. doi: 10.1136/gutjnl-
2017-315940. 
 
Diagram of examination cycles of the Rotterdam Study (RS). RS-I-1 refers to the baseline examination of the original cohort. RS-
I-2, RS-I-3, RS-I-4, and RS-I-5 refer to re-examinations of the original cohort members. RS-II-1 refers to the extension of the 
cohort with persons from the study district that had become 55 years since the start of the study or those of 55 years or over that 
migrated into the study district. RS-II-2 and RS-II-3 refer to re-examinations of the extension cohort. RS-III-1 refers to the 
baseline examination of all persons aged 45 years and over living in the study district that had not been examined already (i.e., 
mainly comprising those aged 45–60 years). RS-III-2 refers to the first re-examination of this third cohort. Similarly, examinations 
RS-I-5, RS-II-3, and RS-III-2 share the same program items. Figure is previously published in: Ikram MA, Brusselle GGO, Murad 
SD, et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur J Epidemiol 2017;32(9):807-50.  
Page 3 of 16 
 
Supplementary Methods II: details on the multiple imputation process 
Variables (range missing values per variable: 0.02 to 10.79%) were imputed using multiple imputation under 
the fully conditioned specification to reduced bias due to missing data(1). Thirty imputed datasets were 
created using the R package mice(2), and analysed separately. Results from these analyses were pooled 
using Rubin’s rules in order to take into account the added uncertainty due to the missing data(3).  
 Multiple imputation  
Software used R version 3.5.0 
Imputation method and key settings Fully conditional specification (package mice version 3.1.0); maximum iterations: 20 
No. of imputed data sets created  30 
Analyses variables 
 
total cholesterol; triglycerides; calcium intake; high density 
lipoprotein cholesterol; body mass index; glucose; weight; 
physical activity; smoking status; systolic blood pressure; 
diastolic blood pressure; ethnicity; education level; alcohol 
consumption; fat intake; waist circumference; kilocalorie 
intake; Dietary Quality; age; anti-diabetic drugs; lipid-
lowering drugs; antihypertensive drugs; fibre intake; study 
cohort; gender; steatosis; protein intake; carbohydrate 
intake; vitamin E intake; potassium intake; magnesium 
intake; phosphorus intake; glomerular filtration rate 
Auxiliary variables  
aspartate transaminase; alanine transaminase; homeostasis 
model assessment of insulin resistance;  hip circumference; 
heart rate; spleen size; creatinine; gamma-
glutamyltransferase 
Treatment of not normally 
distributed continuous variables Predictive mean matching 
Treatment of normally distributed 
variables Linear regression 
Treatment of binary/categorical 
variables (Proportional odds) logistic regression 
Population 
For the imputation we used reliable and completed FFQs. In 
addition participants had to have less than 30% missing on 
study variables. Imputed population (n=4.754). 
 
References: 
1. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical 
research: potential and pitfalls. Bmj 2009;338:b2393. 
2. Buuren van S, Groothuis-Oudhoorn K. mice: Multivariate Imputation by Chained Equations in R. Journal of 
Statistical Software, Articles 2011;45:1-67. 
3. Rubin DB. Multiple imputation for nonresponse in surveys. Wiley London 1987. 
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Supplementary Table 1: Imputation Characteristics 




Demographics   
Age (years) 69.7  (8.8) no missing data 
Female (%) 58.3 no missing data 
Caucasian (%) 97.7 97.6 












Smoking status (%) 
Never / Past or Current 
 
36.7 / 63.3 
 
36.1 / 63.9 
Alcohol (units/d) 0.45 (0.05 – 1.19) no missing data 
Physical Activity (METh/wk) 41.3 (15.8 – 78.5) 40.5 (15.8 – 77.7) 
Caloric Intake (kcal/day) 2031 (1621 – 2514) no missing data 
DQ 7 (6 – 8) no missing data 
PRAL -4.7 (-15.4; 4.4) no missing data 
NEAP 35.7 (29.6 – 42.3) no missing data 
A:P 12.7 (10.2 – 15.4) no missing data 




26.9 (24.5 – 29.7) 
30.2 
69.8 











no missing data 
Biochemistry   
AST (U/L) 24 (21 – 28) 24 (21 – 28) 
ALT (U/L) 18 (15 – 24) 18 (15 – 24) 
GGT (U/L) 23 (17 – 33) 23 (17 – 34) 
Platelets (*109/L) 262 (223 – 305) 262 (223 – 305) 
HOMA-IR  2.6 (1.7 – 4.1) 2.6 (1.7 – 4.1) 
Total Cholesterol (mmol/L) 5.4 (1.1) 5.4 (1.1) 
HDL-C (mmol/L) 1.5 (0.4) 1.5 (0.4) 
Triglycerides (mmol/L) 1.3 (1.0 – 1.7) 1.3 (1.0 – 1.7) 
GFR 76.1 (65.7 – 85.8) 76.1 (65.6 – 85.8) 
Comorbidities   
Metabolic Syndrome (%) 
- WC>88cm (♀) or >120cm(♂) 
- Triglycerides >150mg/dL 
- HDL-C <40mg/dL(♂) or 50mg/dL(♀)  














Diabetes Mellitus (%) 13.2 13.1 
Hypertension (%) 74.0 74.0 
NAFLD (%) 34.4 no missing data 
Data is expressed as mean (SD), median (P25-P75) or percentage.  
Abbreviations ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate aminotransferase; BMI: 
body mass index; DAL: dietary acid load; GFR: glomerular filtration rate; GGT: gamma-glutamyltransferase; HDL-C: high-
density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; NAFLD: non-alcoholic fatty liver 
disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. 
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Supplementary Table 2: Characteristics of the study population 






Demographics    
Age (years) 69.6 (9.2) 70.0 (8.2) 0.180 
Female (%) 59.1 56.8 0.195 
Caucasian (%) 97.4 98.1 0.237 














Smoking status (%) 
Never 










Alcohol (units/d) 0.45 (0.06 – 1.21) 0.43 (0.05 – 1.19) 0.422 
Physical Activity (METh/wk) 43.7 (17.5 – 81.6) 34.6 (13.5 – 70.3) <0.001 
Energy intake 2052 (1642 – 2537) 1996 (1579 – 2456) 0.003 
PRAL (mEq/d) -5.5 (-16.1; 3.4) -2.9 (-13.7; 6.1) <0.001 
NEAP (mEq/d) 35.1 (29.2 – 41.6) 37.0 (30.2 – 43.6) <0.001 
A:P (mEq/d) 12.4 (10.0 – 15.0) 13.3 (10.6 – 16.0) <0.001 




25.8 (23.7 – 28.1) 
40.9 
59.1 





Waist Circumference (cm) 89.1 (11.1) 100.3 (11.4) <0.001 
Biochemistry    
AST (U/L) 24 (21 – 28) 25 (21 – 29) <0.001 
ALT (U/L) 17 (14 – 22) 21 (16 – 29) <0.001 
GGT (U/L) 21 (15 – 30) 28 (20 – 39) <0.001 
Platelets (*109/L) 260 (222 – 303) 266 (225 – 310) 0.053 
HOMA-IR  2.1 (1.5 – 3.1) 4.1 (2.7 – 6.1) <0.001 
Total Cholesterol (mmol/L) 5.5 (1.1) 5.4 (1.1) 0.002 
HDL-C (mmol/L) 1.5 (0.4) 1.3 (0.4) <0.001 
Triglycerides (mmol/L) 1.2 (0.9 – 1.5) 1.6 (1.2 – 2.1) <0.001 
GFR  76 (65 – 85) 76 (66 – 86) 0.272 
<60/>60 (%)  15.7 / 84.3 14.9 / 85.1 0.544 
Comorbidities    
Metabolic Syndrome 
- Waist Circumference 
- Triglycerides  
- HDL-Cholesterol  
- Blood pressure  



















Diabetes Mellitus (%) 7.5 23.7 <0.001 
Hypertension (%) 68.9 83.7 <0.001 
Pooled data based on 30 imputations represent % for categorical variables and for continuous variables mean (SD) or median 
(P25-P75).*P-value is based on ANOVA, Kruskall-Wallis test or Chi-square test and is the comparison between the no NAFLD 
and NAFLD columns. 
Abbreviations  ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate aminotransferase; BMI: 
body mass index; DAL: dietary acid load; GFR: glomerular filtration rate; GGT: gamma-glutamyltransferase; HDL-C: high-
density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; NAFLD: non-alcoholic fatty liver 
disease; NEAP: net endogenous acid production; PRAL; potential renal acid load 
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Supplementary Table 3A: Characteristics per quartile NEAP 
NEAP 
 Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-trend* 
DAL      
PRAL -24.1 (-33.6 ; -17.7) -9.8 (-13.2 ; -6.8) -0.33 (-2.5 ; 2.2) 10.9 (6.8 ; 17.6) <0.001 
NEAP 25.3 (21.9 – 27.8) 32.7 (31.1 – 34.1) 38.7 (37.2 – 40.4) 47.5 (44.6 – 53.0) n/a 
A:P 9.0 (7.5 – 10.4) 11.7 (10.5 – 13.1) 13.9 (12.5 – 15.3) 17.4 (15.3 – 20.0) <0.001 
Demographics       
Age 71.0 (8.7) 69.6 (8.5) 68.8 (8.8) 69.5 (9.2) <0.001 
Female (%) 68.5 60.8 54.0 49.9 <0.001 
Caucasian (%) 97.8 98.2 97.9 96.7 0.160 






















Smoking status (%) 
Never 














Alcohol (units/d) 0.36 (0.03 – 1.08) 0.55 (0.09 – 1.25) 0.52 (0.09 – 1.25) 0.39 (0.03 – 1.16) <0.001 
Physical Activity 
(METh/wk) 
43.2 (17.3 – 78.9) 47.1 (18.0 – 84.0) 38.1 (15.0 – 76.0) 33.3 (13.5 – 70.6) <0.001 
Energy intake (Kcal) 2019 
(1613 – 2457) 
2037 
(1665 – 2491) 
2066 
(1626 – 2532) 
2015 
(1588 – 2551) 
0.525 
Physical examination      
BMI (kg/m2) 26.6 (24.3 – 29.4) 26.6 (24.4 – 29.5) 27.0 (24.6 – 29.7) 27.3 (24.7 – 30.0) 0.012 
Biochemistry      
AST (U/L) 24 (21 – 28) 24 (21 – 28) 24 (21 – 28) 25 (21 – 29) 0.357 
ALT (U/L) 18 (14 – 23) 18 (14 – 24) 19 (15 – 24) 19 (15 – 25) <0.001 
GGT (U/L) 21 (16 – 30) 22 (17 – 32) 23 (17 – 34) 25 (18 – 37) <0.001 
Platelets (*109/L) 267 (232 – 312) 265 (220 – 303) 259 (220 – 300) 259 (220 – 306) 0.002 
HOMA-IR  2.4 (1.7 – 3.6) 2.6 (1.7 – 4.0) 2.6 (1.8 – 4.1) 2.9 (1.9 – 4.7) <0.001 
Total Cholesterol 
(mmol/L) 
5.6 (1.1) 5.5 (1.1) 5.4 (1.1) 5.3 (1.1) <0.001 
HDL-C (mmol/L) 1.5  (0.4) 1.5 (0.4) 1.5 (0.4) 1.4 (0.4) <0.001 
Triglycerides 
(mmol/L) 
1.3 (1.0 – 1.7) 1.2 (1.0 – 1.7) 1.3 (1.0 – 1.7) 1.3 (1.0 – 1.8) 0.708 
GFR  76 (65 – 85) 77 (66 – 86) 76 (66 – 86) 76 (65 – 86) 0.898 
Comorbidities      
Metabolic Syndrome 
- Waist Circumference 
- Triglycerides  
- HDL-Cholesterol  
- Blood pressure  































Diabetes Mellitus (%) 11.2 12.5 11.7 17.1 <0.001 
Hypertension (%) 75.9 72.9 71.8 75.3 0.131 
NAFLD 31.0 31.5 35.8 39.4 <0.001 
Data is expressed as mean (SD), median (P25-P75) or percentage. *P-value is based on ANOVA, Kruskall-Wallis test or Chi-
square test.  
Abbreviations ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate aminotransferase; BMI: 
body mass index; DAL: dietary acid load; GFR: glomerular filtration rate; GGT: gamma-glutamyltransferase; HDL-C: high-
density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; NAFLD: non-alcoholic fatty liver 
disease; NEAP: net endogenous acid production; PRAL; potential renal acid load. 
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Supplementary Table 3B: Characteristics per quartile AP-ratio 
A:P 
 Quartile 1 Quartile 2 Quartile 3 Quartile 4 P-trend* 
DAL      
PRAL -21.4 (-32.4 ; -13.0) -10.4 (-16.4 ; -3.9) -1.7 (-6.8 ; 3.1) 9.2 (3.5 ; 16.4) <0.001 
NEAP 26.1 (21.9 – 30.2) 32.4 (29.5 – 36.0) 37.7 (34.6 – 41.1) 46.2 (42.2 – 52.1) <0.001 
A:P 8.5 (7.2 – 9.5) 11.4 (10.8 – 12.0) 13.9 (13.3 – 14.6) 17.8 (16.4 – 20.1) n/a 
Demographics      
Age 69.9 (8.9) 69.2 (8.6) 69.4 (9.0) 70.4 (8.9) 0.009 
Female (%) 63.5 57.3 57.1 55.3 0.001 
Caucasian (%) 96.6 98.3 97.6 97.9 0.116 






















Smoking status (%) 
Never 
















Alcohol (units/d) 0.38 (0.03 – 1.11) 0.52 (0.09 – 1.22) 0.45 (0.07 – 1.24) 0.45 (0.04 – 1.18) 0.002 
Physical Activity 
(METh/wk) 
45.0 (18.0 – 82.8) 44.4 (18.0 – 82.2) 36.8 (14.5 – 74.5) 32.2 (13.5 – 73.2) <0.001 
Energy intake (kcal) 2099 (1702 – 2598) 
2063 
(1686 – 2505) 
2022 
(1611 – 2526) 
1940 




     
BMI (kg/m2) 26.0 (23.9 – 28.9) 26.9 (24.5 – 29.4) 27.0 (24.8 – 29.8) 27.5 (24.9 – 30.5) <0.001 
Biochemistry      
AST (U/L) 24 (21 – 28) 24 (21 – 28) 24 (21 – 29) 24 (21 – 28) 0.605 
ALT (U/L) 18 (14 – 23) 18 (14 – 23) 19 (15 – 24) 19 (15 – 25) 0.004 
GGT (U/L) 21 (16 – 31) 22 (16 – 31) 24 (17 – 35) 25 (18 – 36) <0.001 
Platelets (*109/L) 268 (228 – 308) 261 (225 – 304) 259 (219 – 304) 261 (221 – 305) 0.054 
HOMA-IR  2.3 (1.6 – 3.5) 2.5 (1.8 – 3.8) 2.7 (1.8 – 4.2) 2.9 (1.8 – 4.7) <0.001 
Total Cholesterol 
(mmol/L) 5.5 (1.1) 5.5 (1.1) 5.4 (1.1) 5.3  (1.1) <0.001 
HDL-C (mmol/L) 1.5 (0.4) 1.5 (0.4) 1.5 (0.4) 1.4 (0.4) 0.012 
Triglycerides 
(mmol/L) 
1.2 (1.0 – 1.7) 1.3 (1.0 – 1.7) 1.3 (1.0 – 1.8) 1.3 (1.0 – 1.8) 0.053 
GFR  77 (66 – 86) 77 (66 – 85) 75 (66 – 86) 75 (64 – 85) 0.241 




- Triglycerides  
- HDL-Cholesterol  
- Blood pressure  

































10.1 12.1 13.6 16.6 <0.001 
Hypertension (%) 71.4 71.5 76.0 77.0 0.005 
NAFLD 28.9 31.8 35.7 41.3 <0.001 
Data is expressed as mean (SD), median (P25-P75) or percentage. *P-value is based on ANOVA, Kruskall-Wallis test or Chi-
square test.  
Abbreviations ALT: alanine aminotransferase; A:P: animal protein to potassium ratio; AST: aspartate aminotransferase; BMI: 
body mass index; DAL: dietary acid load; GFR: glomerular filtration rate; GGT: gamma-glutamyltransferase; HDL-C: high-
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density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance; NAFLD: non-alcoholic fatty liver 
disease; NEAP: net endogenous acid production; PRAL; potential renal acid load.  
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Supplementary Table 4: Logistic regression analyses of DAL-residuals with outcome variable NAFLD 
Total population (n=3882) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 1 (sociodemographic) 
PRAL 0.98 (0.81 – 1.20) 1.16 (0.96 – 1.41) 1.37 (1.13 – 1.66)† 
NEAP 1.03 (0.85 – 1.25) 1.25 (1.04 – 1.52)† 1.40 (1.16 – 1.69)† 
A:P 1.16 (0.96 – 1.41) 1.37 (1.13 – 1.66)† 1.61 (1.33 – 1.95)† 
Model 2 (lifestyle) 
PRAL 0.98 (0.81 – 1.19) 1.14 (0.94 – 1.39) 1.33 (1.10 – 1.62)† 
NEAP 1.03 (0.85 – 1.25) 1.24 (1.02 – 1.50) 1.36 (1.12 – 1.65)† 
A:P 1.16 (0.95 – 1.41) 1.33 (1.10 – 1.62)† 1.56 (1.29 – 1.89)† 
Model 3 (metabolic) 
PRAL 0.97 (0.78 – 1.22) 1.10 (0.88 – 1.38) 1.23 (0.98 – 1.54) 
NEAP 0.98 (0.78 – 1.22) 1.19 (0.96 – 1.49) 1.25 (1.00 – 1.56) 
A:P 1.01 (0.81 – 1.27) 1.13 (0.90 – 1.41) 1.23 (0.98 – 1.53) 
Model 4 (metabolic + DQ) 
PRAL 0.97 (0.77 – 1.22) 1.10 (0.88 – 1.38) 1.23 (0.97 – 1.55) 
NEAP 0.98 (0.78 – 1.23) 1.20 (0.96 – 1.50) 1.25 (1.00 – 1.58) 
A:P 1.01 (0.81 – 1.27) 1.13 (0.90 – 1.41) 1.23 (0.97 – 1.55) 
Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. Bold values indicate P<0.05. † Indicates 
significant values using P < 0.028 as determined by Sidák. 
 
Model 1 (socio-demographic) is adjusted for age, gender, education level, energy intake and study cohort Model 2 (lifestyle) is in 
addition previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in 
addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, GFR, diabetes mellitus and log-
transformed BMI Model 4 (metabolic + DQ) is in addition to the previous model adjusted for DQ.  
 
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: 
glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential 
renal acid load. 
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Supplementary Table 5: Logistic regression analyses of DAL associations with outcome variable 
NAFLD stratified by sex 
Men (n=1619) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 0.95 (0.68 – 1.33) 1.20 (0.87 – 1.64) 1.42 (1.05 – 1.93)† 
NEAP 1.12 (0.80 – 1.55) 1.34 (0.98 – 1.85) 1.49 (1.09 – 2.04)† 
A:P 1.35 (0.98 – 1.85) 1.59 (1.16 – 2.18)† 1.87 (1.37 – 2.55)† 
Model 3 (metabolic) 
PRAL 0.90 (0.61 – 1.33) 1.14 (0.79 – 1.63) 1.30 (0.92 – 1.85) 
NEAP 0.97 (0.66 – 1.42) 1.35 (0.94 – 1.94) 1.34 (0.93 – 1.91) 
A:P 1.06 (0.74 – 1.52) 1.31 (0.92 – 1.87) 1.45 (1.02 – 2.07) 
Women (n=2263) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 1.02 (0.80 – 1.30) 1.05 (0.81 – 1.34) 1.34 (1.04 – 1.72)† 
NEAP 1.00 (0.79 – 1.28) 1.15 (0.90 – 1.47) 1.28 (1.00 – 1.65) 
A:P 1.05 (0.82 – 1.36) 1.20 (0.93 – 1.54) 1.42 (1.11 – 1.82)† 
Model 3 (metabolic) 
PRAL 0.99 (0.75 – 1.32) 1.04 (0.78 – 1.40) 1.22 (0.90 – 1.65) 
NEAP 0.98 (0.74 – 1.30) 1.08 (0.81 – 1.45) 1.17 (0.87 – 1.58) 
A:P 0.91 (0.68 – 1.22) 0.94 (0.70 – 1.26) 1.08 (0.81 – 1.46) 
Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. P-trend is calculated across the quartiles. Bold 
values indicate P<0.05. † Indicates significant values using P < 0.028 as determined by Sidák. 
 
Model 1 (socio-demographic) is adjusted for age, education level, energy intake and study cohort Model 2 (lifestyle) is in 
addition previous model adjusted for past or current smoking, units of alcohol, and physical activity  Model 3 (metabolic) is in 
addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, GFR, diabetes mellitus and BMI 
Model 4 (metabolic + DQ) is in addition to the previous model adjust for DQ.  
 
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: 
glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential 
renal acid load. 
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Supplementary Table 6: Logistic regression analyses of DAL associations with outcome variable 
NAFLD stratified by study cohort 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 1.05 (0.77 – 1.44) 1.10 (0.80 – 1.51) 1.44 (1.07 – 1.95)† 
NEAP 1.00 (0.73 – 1.38) 1.24 (0.90 – 1.69) 1.40 (1.02 – 1.92) 
A:P 1.12 (0.83 – 1.52) 1.30 (0.96 – 1.77) 1.61 (1.18 – 2.19)† 
Model 3 (metabolic) 
PRAL 1.12 (0.79 – 1.60) 1.03 (0.73 – 1.47) 1.24 (0.88 – 1.76) 
NEAP 1.01 (0.71 – 1.45) 1.19 (0.83 – 1.69) 1.16 (0.81 – 1.67) 
A:P 0.94 (0.66 – 1.33) 1.03 (0.73 – 1.45) 1.18 (0.83 – 1.69) 
Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. Bold values indicate P<0.05. † Indicates 
significant values using P < 0.028 as determined by Sidák.  
 
Model 1 (socio-demographic) is adjusted for age, gender, education level and energy intake Model 2 (lifestyle) is in addition 
previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in addition to 
the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, GFR, diabetes mellitus and BMI Model 4 
(metabolic + DQ) is in addition to the previous model adjust for DQ.  
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: 
glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential 
renal acid load. 
  
RS-cohort I (n=1069) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 0.93 (0.64 – 1.34) 0.92 (0.63 – 1.34) 1.07 (0.74 – 1.54) 
NEAP 1.10 (0.77 – 1.57) 1.08 (0.74 – 1.55) 1.10 (0.77 – 1.57) 
A:P 1.21 (0.83 – 1.76) 1.11 (0.77 – 1.60) 1.45 (1.02 – 2.07) 
Model 3 (metabolic) 
PRAL 1.03 (0.67 – 1.58) 1.00 (0.64 – 1.55) 1.19 (0.77 – 1.83) 
NEAP 1.13 (0.74 – 1.72) 1.14 (0.73 – 1.76) 1.22 (0.80 – 1.86) 
A:P 1.22 (0.78 – 1.90) 1.05 (0.68 – 1.62) 1.40 (0.92 – 2.13) 
RS-cohort II (n=1183) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 1.00 (0.70 – 1.42) 1.32 (0.93 – 1.87) 1.73 (1.21 – 2.46)† 
NEAP 0.99 (0.69 – 1.40) 1.31 (0.93 – 1.85) 1.65 (1.17 – 2.32)† 
A:P 1.10 (0.77 – 1.57) 1.61 (1.13 – 2.29)† 1.70 (1.20 – 2.40)† 
Model 3 (metabolic) 
PRAL 0.75 (0.49 – 1.15) 1.20 (0.80 – 1.82) 1.43 (0.94 – 2.19) 
NEAP 0.76 (0.50 – 1.16) 1.14 (0.76 – 1.70) 1.43 (0.95 – 2.16) 
A:P 0.77 (0.51 – 1.18) 1.22 (0.80 – 1.86) 1.11 (0.73 – 1.68) 
RS-cohort III (n=1630) 
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Supplementary Table 7: Logistic regression analyses of DAL associations with outcome variable 
NAFLD stratified by GFR (cut-off 60) 
GFR < 60 (n=597) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 1.00 (0.59 – 1.69) 0.98 (0.58 – 1.68) 1.49 (0.90 – 2.47) 
NEAP 0.89 (0.53 – 1.51) 1.09 (0.66 – 1.82) 1.23 (0.75 – 2.02) 
A:P 1.08 (0.63 – 1.86) 1.33 (0.78 – 2.26) 1.66 (1.00 – 2.74) 
Model 3 (metabolic) 
PRAL 1.05 (0.57 – 1.91) 1.01 (0.55 – 1.87) 1.81 (1.01 – 3.24) 
NEAP 0.86 (0.47 – 1.56) 1.25 (0.70 – 2.23) 1.40 (0.79 – 2.49) 
A:P 1.11 (0.60 – 2.05) 1.39 (0.75 – 2.55) 1.68 (0.94 – 2.99) 
GFR > 60 (n=3285) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 0.99 (0.80 – 1.22) 1.14 (0.92 – 1.41) 1.37 (1.11 – 1.69)† 
NEAP 1.05 (0.85 – 1.30) 1.25 (1.02 – 1.55) 1.38 (1.12 – 1.70)† 
A:P 1.16 (0.94 – 1.43) 1.34 (1.08 – 1.65)† 1.56 (1.27 – 1.93)† 
Model 3 (metabolic) 
PRAL 0.96 (0.75 – 1.23) 1.09 (0.86 – 1.39) 1.18 (0.92 – 1.50) 
NEAP 0.99 (0.78 – 1.27) 1.16 (0.91 – 1.48) 1.20 (0.94 – 1.53) 
A:P 0.93 (0.73 – 1.18) 1.04 (0.82 – 1.33) 1.13 (0.88 – 1.44) 
Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. P-trend is calculated across the quartiles. Bold 
values indicate P<0.05. † Indicates significant values using P < 0.028 as determined by Sidák. 
 
Model 1 (socio-demographic) is adjusted for age, gender, education level, energy intake and study cohort Model 2 (lifestyle) is in 
addition previous model adjusted for past or current smoking, units of alcohol, and physical activity Model 3 (metabolic) is in 
addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, diabetes mellitus and BMI 
Model 4 (metabolic + DQ) is in addition to the previous model adjust for DQ.  
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: 
glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential 
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Supplementary Table 8: Logistic regression analyses of DAL associations with outcome variable 
NAFLD stratified by age (cut-off 65 years) 
Age <65 years old (n=1160) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 1.14 (0.78 – 1.68) 1.32 (0.90 – 1.94) 1.58 (1.10 – 2.28)† 
NEAP 1.06 (0.71 – 1.57) 1.33 (0.91 – 1.96) 1.47 (1.00 – 2.16) 
A:P 1.14 (0.78 – 1.64) 1.33 (0.93 – 1.92) 1.63 (1.13 – 2.37)† 
Model 3 (metabolic) 
PRAL 1.28 (0.83 – 1.98) 1.29 (0.83 – 1.98) 1.39 (0.92 – 2.12) 
NEAP 1.12 (0.71 – 1.76) 1.36 (0.88 – 2.09) 1.29 (0.83 – 2.00) 
A:P 0.99 (0.65 – 1.50) 1.100 (0.73 – 1.66) 1.23 (0.80 – 1.88) 
Age ≥ 65 years old (n=2722) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 0.94 (0.75 – 1.18) 1.05 (0.83 – 1.32) 1.34 (1.07 – 1.69)† 
NEAP 1.02 (0.81 – 1.28) 1.19 (0.95 – 1.49) 1.34 (1.07 – 1.68)† 
A:P 1.14 (0.90 – 1.44) 1.33 (1.06 – 1.68)† 1.56 (1.24 – 1.95)† 
Model 3 (metabolic) 
PRAL 0.87 (0.66 – 1.13) 1.01 (0.77 – 1.32) 1.26 (0.96 – 1.65) 
NEAP 0.92 (0.71 – 1.20) 1.10 (0.84 – 1.43) 1.27 (0.97 – 1.65) 
A:P 0.94(0.72 – 1.23) 1.10 (0.84 – 1.44) 1.21 (0.93 – 1.58) 
Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. P-trend is calculated across the quartiles. Bold 
values indicate P<0.05. † Indicates significant values using P < 0.028 as determined by Sidák.  
Model 1 (socio-demographic) is adjusted for gender, education level, energy intake and study cohort Model 2 (lifestyle) is in 
addition previous model adjusted for past or current smoking, units of alcohol, and physical activity  Model 3 (metabolic) is in 
addition to the previous model adjusted for HDL-cholesterol, triglycerides, metabolic syndrome, GFR, diabetes mellitus and  BMI 
Model 4 (metabolic + DQ) is in addition to the previous model adjust for DQ.  
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: 
glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential 
renal acid load. 
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Supplementary Table 9: Logistic regression analyses of DAL associations with outcome variable 
NAFLD stratified by BMI (cut-off 25) 
BMI < 25 kg/m2 (n=1174) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 1.20 (0.71 – 2.05) 1.11 (0.64 – 1.92) 1.53 (0.91 – 2.58) 
NEAP 1.41 (0.82 – 2.41) 1.30 (0.74 – 2.29) 1.70 (0.99 – 2.90) 
A:P 1.32 (0.79 – 2.19) 1.18 (0.69 – 2.02) 1.63 (0.98 – 2.70) 
Model 3 (metabolic) 
PRAL 1.15 (0.67 – 1.99) 1.00 (0.57 – 1.78) 1.62 (0.95 – 2.78) 
NEAP 1.35 (0.78 – 2.36) 1.18 (0.66 – 2.12) 1.82 (1.05 – 3.18) 
A:P 1.19 (0.70 – 2.03) 1.08 (0.62 – 1.89) 1.60 (0.95 – 2.70) 
BMI ≥ 25 kg/m2 (n=2708) 
 
PRAL n per quartile 
NEAP n per quartile 













Model 2 (lifestyle) 
PRAL 0.91 (0.73 – 1.14) 1.10 (0.88 – 1.38) 1.32 (1.06 – 1.65)† 
NEAP 0.95 (0.76 – 1.19) 1.16 (0.93 – 1.45) 1.31 (1.05 – 1.64)† 
A:P 0.94 (0.75 – 1.18) 1.13 (0.90 – 1.41) 1.34 (1.07 – 1.68)† 
Model 3 (metabolic) 
PRAL 0.88 (0.69 – 1.13) 1.11 (0.87 – 1.41) 1.22 (0.96 – 1.55) 
NEAP 0.92 (0.72 – 1.17) 1.21 (0.96 – 1.53) 1.20 (0.96 – 1.53) 
A:P 0.92 (0.72 – 1.17) 1.10 (0.86 – 1.39) 1.25 (0.98 – 1.59) 
Values are odds ratios with 95% confidence intervals taking quartile 1 as reference. P-trend is calculated across the quartiles. 
 
Model 1 (socio-demographic) is adjusted for age, gender, education level, energy intake and study cohort Model 2 (lifestyle) is in 
addition previous model adjusted for past or current smoking, units of alcohol, and physical activity  Model 3 (metabolic) is in 
addition to the previous model adjusted for HDL-cholesterol, triglycerides metabolic syndrome, GFR and diabetes mellitus Model 
4 (metabolic + DQ) is in addition to the previous model adjust for DQ.  
 
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: 
glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential 
renal acid load. 
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Supplementary Figure 1: Natural cubic splines for the association of DAL-proxies with predicted 
probability of NAFLD in model 1, 2, and 4. 
A. (Sociodemographic) model 1 
 
B. (Lifestyle) model 2 
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Model 1 (socio-demographic) is adjusted for age, gender, education level, energy intake and study cohort 
Model 2 (lifestyle) is in addition previous model adjusted for past or current smoking, units of alcohol, and physical activity   
Model 4 (metabolic + DQ ) is in addition to model 2 adjusted for BMI, HDL-cholesterol, triglycerides, metabolic syndrome, 
GFR, diabetes mellitus, and DQ.  
 
Abbreviations A:P: animal protein to potassium ratio; BMI: body mass index; DAL: dietary acid load; DQ: dietary quality; GFR: 
glomerular filtration rate; NAFLD: non-alcoholic fatty liver disease; NEAP: net endogenous acid production; PRAL; potential 
renal acid load. 
 
Comparison model with DAL-proxy vs model without DAL-proxy  
A. (Sociodemographic) model 1 (PRAL: P=7.4e-5, NEAP: P=1.2e-5, and A:P: P=1.9e-8). 
B. (Lifestyle) model 2 (PRAL: P=2.3e-4, NEAP: P=4.0e-5, and A:P:  P=1.3e-7) 
C. (Metabolic + DQ) model 4 (PRAL: P=0.043, NEAP: P=0.017, and A:P: P=0.014) 
 
 
 
